Skip to main content
. 2015 Apr 14;75(1):52–58. doi: 10.1136/annrheumdis-2014-205726

Figure 1.

Figure 1

(A) Schematic description of the Dose Reduction or Discontinuation of Etanercept in Methotrexate-Treated Rheumatoid Arthritis Patients Who Have Achieved a Stable Low Disease Activity-State study. (B) Patient disposition. ETN, etanercept; MTX, methotrexate; PBO, placebo; QW, once weekly; R, Randomise.